Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review

Boussios, S; Karihtala, P; Moschetta, M; Karathanasi, A; Sadauskaite, A; Rassy, E; Pavlidis, N

Boussios, S (reprint author), Medway NHS Fdn Trust, Acute Oncol Assessment Unit, Windmill Rd, Gillingham ME7 5NY, Kent, England.; Boussios, S (reprint author), AELIA Org, 9th Km Thessaloniki Thermi, Thessaloniki 57001, Greece.

DIAGNOSTICS, 2019; 9 (3):

Abstract

Poly (ADP-ribose) polymerase (PARP) inhibitors are the first clinically approved drugs designed to exploit synthetic lethality, and were first introdu......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索